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Abstract
Background: Thrombocytopenia has been shown to predict mortality. We hypothesize that platelet indices may be more useful 
prognostic indicators. Our study subjects were children one month to 14 years old admitted to our hospital.  
Aim: To determine whether platelet count, plateletcrit (PCT), mean platelet volume (MPV) and platelet distribution width 
(PDW) and their ratios can predict mortality in hospitalised children.
Methods: Children who died during hospital stay were the cases. Controls were age matched children admitted contempora-
neously. The first blood sample after admission was used for analysis. Receiver operating characteristic (ROC) curve was used 
to identify the best threshold for measured variables and the ratios studied. Multiple regression analysis was done to identify 
independent predictors of  mortality.
Results: Forty cases and forty controls were studied. Platelet count, PCT and the ratios of  MPV/Platelet count, MPV/PCT, 
PDW/Platelet count, PDW/PCT and MPV x PDW/Platelet count x PCT were significantly different among children who 
survived compared to those who died. On multiple regression analysis the ratio of  MPV/PCT, PDW/Platelet count and MPV/
Platelet count were risk factors for mortality with an odds ratio of  4.31(95% CI, 1.69-10.99), 3.86 (95% CI, 1.53-9.75), 3.45 (95% 
CI, 1.38-8.64) respectively. In 67% of  the patients who died MPV/PCT ratio was above 41.8 and PDW/Platelet count was above 
3.86. In 65% of  patients who died MPV/Platelet count was above 3.45.
Conclusion: The MPV/PCT, PDW/Platelet count and MPV/Platelet count, in the first sample after admission in this case 
control study were predictors of  mortality and could predict 65% to 67% of  deaths accurately.
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Introduction
In-hospital mortality depends on the severity of  the ill-
ness at the time of  admission1. Severity of  illness scores 
have been developed to predict the mortality in the In-
tensive Care Unit (ICU)2. Scoring systems such as the PSI 
(Physiologic Stability Index), PRISM score (Pediatric Risk 
of  Mortality), SICK score (Signs of  Inflammation that 
Can Kill) are severity of  illness scores used in children2–5.
In 2000 Vanderschueren and colleagues showed that 
thrombocytopenia by itself  effectively predicts mortality 
in adults admitted in ICU and is complementary to differ-
ent established scoring systems6.
In a case control study of  145 patients with sepsis and 
143 controls, Guclu showed that, mean platelet volume 
(MPV) and platelet distribution width (PDW) were useful 
in diagnosis of  sepsis and patients with PDW of  more 
than 18% have a higher risk of  death7.
Thrombocytopenia occurring in critically ill patients is 
the result of  hemodilution, increased platelet consump-
tion, increased platelet destruction (immune mecha-
nisms)8 and increased platelet sequestration9. Septicemia 
related destruction of  platelets increases production and 
release into the peripheral blood of  larger and younger 
platelets10. Later, however there may be bone marrow 
suppression7.
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Platelet volume indices, estimated by automated blood 
cell analysers, show the changes that accompany the al-
terations in platelet counts11. Platelet parameters such as 
MPV and PDW (reflection of  the variation of  the platelet 
size in the circulation12 have been routinely available to 
the clinicians for some time. However their significance 
in various platelet disorders have only been studied re-
cently7.
Septic rat models have shown that PDW and MPV in-
crease in sepsis with appearance of  large and heavy plate-
lets in circulation13. Canine models of  endotoxemia have 
shown that the platelet count and PCT decreased where 
as MPV and PDW are increased showing that platelet 
counts are correlated positively with PCT, but correlate 
negatively with MPV and PDW during early endotoxemia 
in dogs14.
In human studies, Nelson and Kehl reported that in acute 
infection there was platelet consumption and it was as-
sociated with an increase in MPV15. Becchi et al noted 
that MPV at an early stage of  sepsis was important prog-
nostically16. MPV increased during the admission period 
in those who died, compared to survivors16.  In neonates 
with sepsis, a low platelet count and an increase in MPV 
has been observed by Guida et al17. Patrick et al demon-
strated that neonates with late onset sepsis (bacteremia 
after 3 days of  age) had a dramatic increase in MPV and 
PDW18.
We hypothesize that as the MPV and PDW increase and 
platelet count and PCT decrease in sick children, intui-
tively, the ratio of  MPV to PCT; MPV to Platelet count, 
PDW to PCT, PDW to platelet count and the ratio of  the 
product of  MPV and PDW to the product of  PCT and 
platelet count could be candidate markers of  severity of  
illness and that these may be useful to predict mortality.
To the best of  our knowledge these ratios have not been 
studied in children in this context. We did this preliminary 
case control study to test this hypothesis.
 
Methods
The case control study was done in a tertiary care ur-
ban hospital (St. Stephens Hospital) in Delhi – the capi-
tal city of  India, and the data relates to patients admit-
ted to a tertiary post-graduate teaching hospital between 
21/08/2009 to 10/03/2011. The department of  Paediat-
rics is manned by 5 full time consultants and 14 resident 
doctors 9 of  who are fully trained paediatricians working 
as Senior Registrars and the remaining are Senior House 
doctors in training for the Diplomate of  the National 
Board in Paediatrics.
 
All children between the ages of  one month to fourteen 
years who died in the hospital were included. Controls 
were children of  matching age (± one year except in in-
fants where they were matched to within one month of  
the cases) admitted contemporaneously and who sur-
vived hospital stay. Forty events (deaths) were examined. 
Table 1 shows the primary system involved that neces-
sitated hospitalization.
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Table 1: Primary System Involved in Cases (died) and Controls (survivors). 
 
    Number of 
Patients 
Cases Controls 
  Total patients 80 40 40 
  Primary system involved at the 
time of admission 
      
1. Neurological 18 10 8 
2. Respiratory 13 6 7 
3. Cardiovascular 7 5 2 
4. Gastrointestinal 13 5 8 
5. Hepatic 6 3 3 
6. Infectious 22 13 9 
7. Others 1 1 0 
  Progression to MODS 15 15 0 
  Surgical cases 6 5 1 
 
         MODS=multiorgan dysfunction syndrome 
This was a retrospective analysis of  routinely collected 
data. Ethical approval was obtained from the ethics com-
mittee of  St. Stephens Hospital, Delhi for this analysis of  
anonymised data. The first blood count immediately after 
admission was analysed.
Complete blood count was done using Baeckmen Coulter 
electrical impedance method. Platelet count, MPV, PCT 
and PDW were noted.
Sample size calculation
Based on the results from the canine model13 we an-
ticipated a 30% increase in MPV. With local laboratory 
norms for MPV: 9 fl (95% CI 7.4-10.4) and the PCT: 0.28 
% (95% CI 0.19-0.38). We calculated we would need a 
sample size of  34 (17 cases and 17 controls) for a study 
with 80% power at the 5% level of  confidence. In this 
retrospective study, given that there is no equivalent study 
in children, we used twice that sample size (40 cases and 
40 controls) which was predicted using the canine model.
Statistical analysis
Statistical analysis was done using Stata 12.1 software. 
Quantitative variables were compared between two 
groups using Wilcoxon Rank sum (Mann-Whitney) test. 
ROC curve analysis was used to identify the best thresh-
old value for the measured variables and the ratios stud-
ied. Proportion of  cases above and below these thresh-
olds were compared between alive and dead using Chi 
Square Test. Using these threshold values the odds ratio 
with 95% confidence interval was calculated using logistic 
regression analysis. Multiple logistic regression was ap-
plied to identify independent predictors of  mortality. All 




There were 40 cases and 40 controls in the study. The 
sex ratio (female: male) was 1:1.8 and 1:1.3 among those 
who died and survived respectively. The mean age among 
cases was 4.0 years (SD 3.86) and of  controls was 3.4 
years (SD 3.12).   Twenty two children were below the age 
of  1 year, 38 children between ages of  1 and 5 years and 
20 children were above the age of  5 years.
 
Table 2 shows the distribution of  platelet count, MPV, 
PCT, PDW. The platelet count was significantly lower in 
those who died compared to those who survived. The 
mean platelet count among those who died was 217x103 
cells/µL and among survivors it was 312 x 103 cells/µL 
(p= 0.01). Sixty seven percent of  the patients with platelet 
count less than 245x103 cells/µL died as against 33% with 
a platelet count of  more than 245 x103 cells/µL (p<0.01). 
The odds ratio for platelet count was 3.86 (95% CI: 1.53 
- 9.57). The area under the ROC curve looking at platelet 
count is 0.66
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Table 2: Platelet indices among cases and controls. 
  
Characteristic Alive N (%) N=40 
Dead  N (%) 




(x103 cells /µL) 
   Mean ± SD 
   > 245 
   ≤ 245 
  
  
312.72 ± 164.57 
















3.86 (1.53   9.57) 
MPV (fl) 
   Mean ± SD 
   ≤ 8.5 
   > 8.5 
  














1.50 (0.62   3.61) 
PCT (%) 
   Mean ± SD 
   > 0.217 
   ≤ 0.217 
  














2.50 (1.02   6.15) 
PDW 
   Mean ± SD 
   ≤ 16.4 
   > 16.4 
  














0.81 (0.34   1.97) 
N=number of patients 
The mean value of  Plateletcrit (PCT) among those who 
died was 0.18 % compared to 0.26% among controls (sur-
vivors) (p value<0.01). A PCT of  less than 0.217 % was 
observed in sixty two percent of  the patients who died 
(p-value 0.04). The odds ratio of  death was 2.50 (95% 
CI 1.02-6.15) in patients with a PCT <0.217%. The area 
under ROC curve was 0.67 for PCT. 
The mean MPV for those who died was 8.7 fl and that 
among survivors was 8.6 fl (p value: 0.92). The mean val-
ue of  PDW in cases was 16.44 and among controls was 
16.41 (p value: 0.89). MPV and PDW were not statisti-
cally different between the cases and the controls.
Table 3 shows the ratios of  the platelet indices. The ra-
tio for MPV/ Platelet count MPV/ PCT, PDW/Platelet 
count, PDW/ PCT and MPV x PDW/ Platelet count x 
PCT were significantly different in the two groups when 
logarithmic scale was applied. The area under ROC curve 
for all the above mentioned ratios was between 65% and 
67%. Sixty seven percent of  the patients died if  MPV/
PCT was more than 41.8 (p value <0.01) and if  PDW/
Platelet count was more than 3.86 (p value<0.01) and 
65% mortality was seen in patients with MPV/Platelet 
count above 3.45 (p value <0.01).
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Discussion
We found platelet count, PCT and the ratios of  MPV/
Platelet count, MPV/PCT, PDW/Platelet count, PDW/
PCT and MPV x PDW/Platelet count x PCT were sig-
nificantly different for children who survived compared 
to those who died.
 
Platelet count
We found that if  the count had not increased above 245 
x 103 cells/µL the chance of  death is significantly higher. 
In our study we found that the platelet count was lower 
in patients who died than those who survived. Sixty seven 
percent of  patients died in whom the platelet count was 
lower than 245 x103 cells/µL. The normal platelet count 
in healthy individuals is between 150 -400 x103 cells/µL. 
PCT is a reflection of  the platelet count and platelet size, 
we found that the PCT in those who died was signifi-
cantly different from those who survived in parallel with 
the platelet count findings.
Our results are similar to those by Vanderschueren and 
colleagues who  have shown that in adults admitted in 
the ICU, patients who died had a lower platelet count 
than survivors6.  Moreau et al found that on the receiver 
operating characteristic curve, the platelet count decline 
of  28.3% was associated with the best discrimination be-
tween survivors and non survivors. Thirty seven percent 
of  those who died had a decline of  more than 28.3% 
whereas 20.9% of  survivors had this platelet decline19. 
Thrombocytopenia was associated with longer ICU stays, 
a higher incidence of  bleeding events, greater transfusion 
requirements and higher mortality6,19. In sepsis however 
the platelet count increases20. It could  be that the inabil-
ity of  the bone marrow to increase the production of  
platelets and release them into the circulation during sep-
sis maybe a risk factor for death rather than a marker of  
poor prognosis.
Platelet Distribution Width (PDW)
We did not find a difference between the PDW of  those 
who died compared to survivors.
Patrick et al studied PDW in neonates with late onset sep-
sis. He found that PDW increased with sepsis18. We did 
not analyse children with sepsis separately as it was not 
part of  the protocol for the study.
 
Table 3: Ratio of Platelet Indices (Cases and Controls). 
 
Characteristic Alive N (%) N=40 
Dead N (%) 




   Mean ± SD 
   ≤ 0.035 
   > 0.035 
  














3.45 (1.38   8.64) 
MPV/PCT 
   Mean ± SD 
   ≤ 41.8 
   > 41.8 
  














4.31 (1.69   10.99) 
PDW/Plat 
   Mean ± SD 
   ≤ 0.07 
   > 0.07 
  














3.86 (1.53   9.75) 
PDW/PCT 
   Mean ± SD 
   ≤ 81.3 
   > 81.3 
  














2.78 (1.12   6.87) 
Platelet Index 
   Mean ± SD 
   ≤ 2.88 
   > 2.88 
  














3.86 (1.53   9.75) 
 
Abbreviations 
MPV: Mean Platelet Volume 
PDW: Platelet Distribution Width 
Plat: Platelet count 
PCT: Plateletcrit 
Platelet Index: MPV x PDW/PCT x Plat 
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Mean Platelet Volume (MPV)
We found no difference in the MPV between the dead 
and the survivors.
Van Der Leile et al have shown an increase in MPV in 
septicemic patients10. He postulated that with sepsis there 
is increased thrombocytosis and this result in increase 
dmegakaryocyte ploidy and an increase in MPV. Again 
we did not do a subgroup analysis of  patients with sep-
ticaemia.
MPV/PCT
We found that the ratio of  MPV /PCT was a better pre-
dictor of  mortality than platelet count or plateletcrit by 
themselves. This suggests that although there was no sta-
tistically significant difference in MPV and PDW between 
those who survived and those who died, there must have 
been subtle increase in the MPV and a correspondence 
decrease in PCT such that the ratio of  MPV / PCT was 
more meaningful as an indicator of  survival than either 
of  the parameters taken alone. This could have resulted 
from an increase in the production of  platelets and the 
release of  immature and larger platelets into the circula-
tion to meet the increase demands.
We found on multiple regression analysis that the ratio 
of  MPV/PCT, PDW/Platelet count and MPV/Platelet 
count were predictors of  mortality with the Odds ratio 
of  4.31, 3.86 and 3.45 respectively.
We had hypothesised that these ratios would be increased 
in non survivors. This is the first study where these pa-
rameters have been examined as a ratio.
Ours is a retrospective case control study of  data and 
has all the attendant limitations of  a retrospective study. 
Further prospective studies are needed to confirm these 
findings. We used the first blood sample after admission. 
Furthermore we studied only single values of  these pa-
rameters, and have not investigated the trend during the 
course of  illness within the hospital. It is possible that 
counts may vary with the duration of  illness prior to ad-
mission. It is also a drawback that we have not taken into 
consideration the duration of  illness prior to hospitalisa-
tion.
In the studies for PRISM III score looking at multiple 
factors that predict mortality in sick children admitted to 
intensive care the best indicators were abnormal pupil-
lary reflexes [OR 9.9 (95% CI, 3.5-28.4)], acidosis [OR 
3.1 (95% CI, 2.0-4.9)], blood urea nitrogen concentra-
tion [OR 1.03 (95% CI, 1.01-1.04)], and white blood cell 
count OR 1.02 (95% CI, 1.01-1.03)(21). The odds ratio of  
4.31 that we have shown for MPV/PCT, 3.86 for PDW/
Platelet count and 3.45 for MPV/Platelet count suggests 
that these are likely to have a good predictive ability if  
included in a severity of  illness scoring system.  This may 
be used in scoring systems to predict hospital survival. 
Further studies are needed to see if  it can improve predic-
tive ability of  existing severity of  illness scoring systems.
  
Conclusion
The MPV/PCT, PDW/Platelet count and MPV/Platelet 
count, in the first sample after admission in this case con-
trol study were predictors of  mortality and could predict 
65% to 67% of  deaths accurately.
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